Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment

被引：0
|
作者：
Li Cavoli Gioacchino [1 ]
Zagarrigo Carmela [1 ]
Servillo Franca [1 ]
Coglitore Mario [1 ]
Schillaci Onofrio [1 ]
Tralongo Angelo [1 ]
Rotolo Ugo [1 ]
机构：
[1] Nephrology and Dialysis,Civic and Di Cristina Hospital
来源：
中华医学杂志（英文版） | 2013年 / 126卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R457 [血液疗法];
学科分类号：
100215 ;
摘要：
To the editor:We read with interest the article of Zheng et al~1on sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation(ASCT)in patients with multiple myeloma(MM).
引用
收藏
页码：1795 / 1795
相关论文
共 50 条
  • [21] First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
    Zinke-Cerwenka, W.
    Stojakovic, T.
    Rohn, A.
    Ziegler, I.
    Emberger, W.
    Sipurzynski, S.
    Linkesch, W.
    Neumeister, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S149 - S149
  • [22] Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
    Sivgin, Serdar
    Baldane, Suleyman
    Kaynar, Leylagul
    Kurnaz, Fatih
    Baskol, Mevlut
    Kula, Mustafa
    Eroglu, Celalettin
    Deniz, Kemal
    Eser, Bulent
    Unal, Ali
    Cetin, Mustafa
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2013, 5 (01):
  • [23] HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients
    Minnema, Monique C.
    Nasserinejad, Kazem
    Hegenbart, Ute
    Ypma, Paula F.
    Wu, Ka Lung
    Kersten, Marie Jose
    Croockewit, Sandra
    Zweegman, Sonja
    Tick, Lidwine
    Broijl, Annemiek
    Koene, Harry
    Bos, Gerard M. J.
    Sonneveld, Pieter
    Schonland, Stefan O.
    EJHAEM, 2024, 5 (04): : 815 - 819
  • [24] Sequential Therapy with Cyclophosphamide, Bortezomib and Dexamethasone Followed By Autologous Stem Cell Transplant Is Safe and Highly Effective in AL Amyloidosis
    Basset, Marco
    Milani, Paolo
    Foli, Andrea
    Nuvolone, Mario
    Ripepi, Jessica
    Bozzola, Margherita
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD, 2019, 134
  • [25] EFFICACY AND SAFETY OF BORTEZOMIB COMBINED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE TREATMENT OF MGRS
    Zhao, Liang
    Ren, Guisheng
    Guo, Jinzhou
    Xu, Weiwei
    Liu, Zhi Hong
    Huang, Xianghua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I79 - I79
  • [26] Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation
    Y-S Chen
    X-J Kong
    X-H Zhang
    X-L Yin
    Bone Marrow Transplantation, 2014, 49 : 984 - 985
  • [27] Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation
    Chen, Y-S
    Kong, X-J
    Zhang, X-H
    Yin, X-L
    BONE MARROW TRANSPLANTATION, 2014, 49 (07) : 984 - 985
  • [28] Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
    M. Hasib Sidiqi
    Mohammed A. Aljama
    Irbaz Bin Riaz
    Angela Dispenzieri
    Eli Muchtar
    Francis K. Buadi
    Rahma Warsame
    Martha Q. Lacy
    David Dingli
    Nelson Leung
    Wilson I. Gonsalves
    Prashant Kapoor
    Taxiarchis V. Kourelis
    William J. Hogan
    S. Vincent Rajkumar
    Shaji K. Kumar
    Morie A. Gertz
    Blood Cancer Journal, 8
  • [29] Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
    Sidiqi, M. Hasib
    Aljama, Mohammed A.
    Bin Riaz, Irbaz
    Dispenzieri, Angela
    Muchtar, Eli
    Buadi, Francis K.
    Warsame, Rahma
    Lacy, Martha Q.
    Dingli, David
    Leung, Nelson
    Gonsalves, Wilson I.
    Kapoor, Prashant
    Kourelis, Taxiarchis V.
    Hogan, William J.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Gertz, Morie A.
    BLOOD CANCER JOURNAL, 2018, 8
  • [30] SEQUENTIAL VAD (VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE) AND VTD (BORTEZOMIB, THALIDOMIDE, DEXAMETHASONE) INDUCTION FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AND MAINTENANCE TREATMENT WITH BORTEZOMIB FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: INTERIM RESULTS OF PHASE 11 TRIAL
    Yoon, S. S.
    Kim, H. J.
    Lee, D. S.
    Eom, H. S.
    Jang, J. H.
    Chung, J. S.
    Kang, H. J.
    Kim, C. S.
    Kim, K. K.
    Lee, J. H.
    Lee, S. J.
    Min, Y. H.
    Seong, C. M.
    Sohn, S. K.
    Suh, C.
    Won, J. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 86 - 87
12345